GLP-1 Drugs Recommended by WHO for Adult Obesity

WHO recommends GLP-1 drugs for adult obesity management, guidance in JAMA defines long-term use as six months or more.
Regulatory approvals (FDA) preceded WHO guidance drafted by expert committee.
GLP-1 drugs mimic a hormone to signal fullness and reduce appetite.
Over 890 million adults are obese, causing 3.7 million annual deaths.
WHO's recommendation is conditional due to need for more data and lower prices.
1 in 8 U.S. adults take GLP-1 drugs amid obesity framing shift.

Health | Public Health | Medicine

United States

1 month ago